Search results
Gateway - Quartz
Quartz· 1 day agoEvery pharmaceutical company is constantly searching for its next blockbuster — the billion-dollar drug that dominates a market, brings in hordes of customers ...
Teva Engages In Settlement Talks Over Medicare Kickback Allegations - Teva Pharmaceutical Indus...
Benzinga· 18 hours agoCiting a filing, Reuters noted the company is requesting the Boston-based 1st U.S. Circuit Court of Appeals to delay its upcoming appeal hearing. Also Read: Generics Player ...
3 Top Stocks I'd Buy Today and Hold Forever Without Any Hesitation
The Motley Fool via AOL· 1 day agoThe thing that makes Vertex different is that it has a lock on...of years. Rather than allow its...
Ozempic is 1,300% more expensive in the U.S. vs the U.K.—so the boss of Novo Nordisk is being hauled...
Fortune via Yahoo Finance· 2 days agoThat valuation also makes it more valuable than the entire economy in its native Denmark. Novo’s net...
Mounjaro Is Targeting Another Multibillion-Dollar Market: Is Eli Lilly Stock a Buy?
Motley Fool via Yahoo Finance· 4 days agoThat's good news for Eli Lilly, but here's the not-so-good news for the company: Other drugmakers...
Drugmakers frequently pay physicians to endorse products on social media, study finds
BenefitsPRO· 7 days agoOpen Payments is a comprehensive database that allows the public to see how much money doctors...
Alchem accused of pharma price fixing by EU watchdog
Reuters· 5 days agoThe European Commission, which acts as the EU competition watchdog, said...Commission suspects Alchem of breaching EU antitrust rules by participating in...
Lilly’s Weight-Loss Drug Is a Huge Hit. Its CEO Wants to Replace It ASAP.
The Wall Street Journal· 5 days agoGLP-1 drugs like tirzepatide are large, complex molecules. Some early efforts at other drugmakers to...
Teva in talks to settle US lawsuit alleging MS drug kickbacks
Reuters· 2 days ago, opens new tab said it is in active talks to settle a U.S. Department of Justice lawsuit alleging...
US Drug Negotiations Plan Shifts Focus for Rare Disease Programs
Bloomberg Law· 2 days agoThe rare disease community is pushing for changes in the Inflation Reduction Act’s drug price-setting scheme as it leads more drugmakers and investors to reconsider development ...